• reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program

    Monday November 8th 2021

  • Agomab Therapeutics to acquire Origo Biopharma

    Thursday October 28th 2021

  • Thirona closes financing round with HERAN Partners and Borski Fund

    Thursday October 28th 2021

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Mithra announces Estelle® launch in Belgium

    Thursday October 21st 2021

  • Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes

    Wednesday October 20th 2021

  • The Board of Directors confirms Leon Van Rompay as Mithra’s CEO

    Monday October 18th 2021

  • miDiagnostics to pilot innovative, fast COVID-19 PCR testing solutions at Brussels Airport

    Friday October 15th 2021

  • Your news here?

  • VIB celebrates 25 years of groundbreaking research

    Wednesday October 13th 2021

  • Oxurion NV announces first patient dosed in its Phase 2 Study evaluating THR-687 for the treatment of Diabetic Macular Edema (DME)

    Wednesday October 13th 2021

  • Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson to retire, Effective December 31, 2021

    Tuesday October 12th 2021


Strategic Partners